Amgen (NASDAQ:AMGN), a United States-based biopharmaceutical company, announced on Friday that it has increased its dividend for the first quarter of 2022.
The company has declared a dividend of USD1.94 per share for the first quarter of 2022, up 10% compared to the year-ago period.
The dividend will be paid to shareholders of record at 15 February 2022 on 8 March 2022.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development